Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA vs BACIL PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BLISS GVS PHARMA BACIL PHARMA BLISS GVS PHARMA/
BACIL PHARMA
 
P/E (TTM) x 13.2 -90.7 - View Chart
P/BV x 1.4 7.8 17.3% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 BLISS GVS PHARMA   BACIL PHARMA
EQUITY SHARE DATA
    BLISS GVS PHARMA
Mar-23
BACIL PHARMA
Mar-23
BLISS GVS PHARMA/
BACIL PHARMA
5-Yr Chart
Click to enlarge
High Rs9110 943.7%   
Low Rs674 1,833.8%   
Sales per share (Unadj.) Rs72.20-  
Earnings per share (Unadj.) Rs7.4-0.2 -4,254.5%  
Cash flow per share (Unadj.) Rs9.2-0.2 -5,450.1%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs84.01.9 4,502.6%  
Shares outstanding (eoy) m104.155.89 1,768.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.10-  
Avg P/E ratio x10.8-38.6 -27.9%  
P/CF ratio (eoy) x8.7-39.6 -21.9%  
Price / Book Value ratio x0.93.6 26.4%  
Dividend payout %6.80-   
Avg Mkt Cap Rs m8,26239 21,014.7%   
No. of employees `000NANA-   
Total wages/salary Rs m8621 100,194.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,5160-  
Other income Rs m1781 15,466.1%   
Total revenues Rs m7,6941 669,020.9%   
Gross profit Rs m1,173-2 -55,341.0%  
Depreciation Rs m1870 622,433.3%   
Interest Rs m1040 518,200.0%   
Profit before tax Rs m1,061-1 -103,992.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2930-   
Profit after tax Rs m767-1 -75,230.4%  
Gross profit margin %15.60- 
Effective tax rate %27.70 70,526.5%   
Net profit margin %10.20- 
BALANCE SHEET DATA
Current assets Rs m6,9742 304,526.6%   
Current liabilities Rs m1,9330 690,210.7%   
Net working cap to sales %67.10- 
Current ratio x3.68.2 44.1%  
Inventory Days Days390- 
Debtors Days Days1,8710- 
Net fixed assets Rs m4,5628 58,331.7%   
Share capital Rs m10465 159.6%   
"Free" reserves Rs m8,646-54 -15,928.3%   
Net worth Rs m8,75011 79,618.0%   
Long term debt Rs m4070-   
Total assets Rs m11,53510 114,096.9%  
Interest coverage x11.2-50.0 -22.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70-   
Return on assets %7.6-9.9 -76.1%  
Return on equity %8.8-9.3 -94.6%  
Return on capital %12.7-9.1 -139.2%  
Exports to sales %00-  
Imports to sales %00-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,6180-   
Fx outflow Rs m1,2250-   
Net fx Rs m4,3940-   
CASH FLOW
From Operations Rs m343-1 -23,342.9%  
From Investments Rs m-78-1 6,681.9%  
From Financial Activity Rs m-2491 -39,585.7%  
Net Cashflow Rs m30-2 -1,502.5%  

Share Holding

Indian Promoters % 35.0 42.7 82.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 22.0 0.0 -  
FIIs % 15.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.0 57.3 113.4%  
Shareholders   40,758 6,628 614.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BLISS GVS PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BLISS GVS PHARMA vs BACIL PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BLISS GVS PHARMA vs BACIL PHARMA Share Price Performance

Period BLISS GVS PHARMA BACIL PHARMA S&P BSE HEALTHCARE
1-Day -0.66% 1.95% 1.18%
1-Month -8.51% 43.43% -0.75%
1-Year 59.31% 161.25% 61.82%
3-Year CAGR 4.12% 67.38% 18.16%
5-Year CAGR -8.63% 44.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the BLISS GVS PHARMA share price and the BACIL PHARMA share price.

Moving on to shareholding structures...

The promoters of BLISS GVS PHARMA hold a 35.0% stake in the company. In case of BACIL PHARMA the stake stands at 42.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BLISS GVS PHARMA and the shareholding pattern of BACIL PHARMA.

Finally, a word on dividends...

In the most recent financial year, BLISS GVS PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.8%.

BACIL PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of BLISS GVS PHARMA, and the dividend history of BACIL PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.